We are live on
!
Find out more
Los Angeles Capital Management Portfolio holdings
AUM
$27.2B
1-Year Est. Return
43.16%
This Fund
S&P 500
This Quarter
Est. Return
+13.16%
1 Year Est. Return
+43.16%
3 Year Est. Return
+177.72%
5 Year Est. Return
+262.7%
10 Year Est. Return
+1,121.27%
AUM
$22.5B
AUM Growth
+$1.93B
(+9.4%)
Cap. Flow
+$256M
Cap. Flow
% of AUM
1.14%
Top 10 Holdings %
Top 10 Hldgs %
26.61%
Holding
1,346
New
164
Increased
337
Reduced
605
Closed
194
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$426M |
| 2 |
Deere & Co
DE
|
+$212M |
| 3 |
NVIDIA
NVDA
|
+$149M |
| 4 |
W.W. Grainger
GWW
|
+$140M |
| 5 |
Netflix
NFLX
|
+$135M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Pfizer
PFE
|
+$196M |
| 2 |
Home Depot
HD
|
+$189M |
| 3 |
Gilead Sciences
GILD
|
+$145M |
| 4 |
Oracle
ORCL
|
+$145M |
| 5 |
Microsoft
MSFT
|
+$124M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 32.24% |
| 2 | Financials | 13.5% |
| 3 | Healthcare | 12.02% |
| 4 | Consumer Discretionary | 11.94% |
| 5 | Industrials | 11.18% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
DVAX
726
DELISTED
Dynavax Technologies
DVAX
| $799K | ﹤0.01% |
81,480
-1,229
| -1% | -$13.1K |
|
727
Village Super Market
VLGEA
$638M
| $798K | ﹤0.01% |
34,873
-761
| -2% | -$17.4K |
|
728
Great Southern Bancorp
GSBC
$888M
| $798K | ﹤0.01% |
15,743
-367
| -2% | -$20.8K |
|
729
Murphy USA
MUSA
$10.4B
| $795K | ﹤0.01% |
3,080
+253
| +9% | +$65.8K |
|
730
Cheesecake Factory
CAKE
$5.57B
| $792K | ﹤0.01% |
22,605
-3,580
| -14% | -$133K |
|
731
Ducommun
DCO
$3.01B
| $791K | ﹤0.01% |
14,463
-712
| -5% | -$38.8K |
|
732
Church & Dwight Co
CHD
$24B
| $791K | ﹤0.01% |
8,949
-119
| -1% | -$9.93K |
|
733
Jefferies Financial Group
JEF
$12.9B
| $789K | ﹤0.01% |
+24,866
| New | +$898K |
|
734
Alamo Group
ALG
$1.99B
| $784K | ﹤0.01% |
+4,257
| New | +$700K |
|
735
MasTec
MTZ
$23B
| $783K | ﹤0.01% |
8,295
| – | – |
|
736
Arcosa
ACA
$7.12B
| $783K | ﹤0.01% |
+12,403
| New | +$728K |
|
|
IAS
737
DELISTED
Integral Ad Science
IAS
| $778K | ﹤0.01% |
54,505
+17,835
| +49% | +$200K |
|
738
Kirby Corp
KEX
$7.26B
| $775K | ﹤0.01% |
+11,120
| New | +$766K |
|
739
Century Casinos
CNTY
$35.2M
| $775K | ﹤0.01% |
105,734
+1,618
| +2% | +$13.5K |
|
740
Acadia Healthcare
ACHC
$2.82B
| $768K | ﹤0.01% |
10,630
-13,710
| -56% | -$1.07M |
|
741
Unum
UNM
$14.7B
| $767K | ﹤0.01% |
19,393
-327,936
| -94% | -$13.5M |
|
742
StoneX
SNEX
$8.05B
| $764K | ﹤0.01% |
+37,336
| New | +$710K |
|
743
Capital One
COF
$137B
| $763K | ﹤0.01% |
7,938
+3,770
| +90% | +$395K |
|
744
SouthState Bank Corp
SSB
$10.8B
| $759K | ﹤0.01% |
10,654
-1,670
| -14% | -$130K |
|
745
GoDaddy
GDDY
$12.7B
| $758K | ﹤0.01% |
+9,757
| New | +$753K |
|
746
Central Pacific Financial
CPF
$1B
| $750K | ﹤0.01% |
41,921
-1,600
| -4% | -$34.1K |
|
747
Truist Financial
TFC
$64.7B
| $745K | ﹤0.01% |
21,857
-1,030,578
| -98% | -$45M |
|
748
Mercantile Bank Corp
MBWM
$1.06B
| $739K | ﹤0.01% |
24,175
-276
| -1% | -$9.24K |
|
|
ITCI
749
DELISTED
Intra-Cellular Therapies Inc.
ITCI
| $738K | ﹤0.01% |
13,625
-1,217
| -8% | -$58.8K |
|
750
iQIYI
IQ
$1.31B
| $737K | ﹤0.01% |
+101,211
| New | +$695K |
|
Similar funds
FDCDDQ
WP
N
PCH
VAI
Los Angeles Capital Management's Q1 2023 Portfolio in Review
As of Q1 2023, Los Angeles Capital Management held 1,346 positions worth $22.5B, up 9.4% from $20.6B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Los Angeles Capital Management's Q1 2023 filing shows 164 new, 337 increased, 605 reduced and 194 closed positions. Its largest new stake was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M. The largest sale was Pfizer, an estimated $196M.
By sector, the portfolio is most concentrated in Technology at 32% of assets, up from 28% a quarter earlier, followed by Financials and Healthcare.
- Los Angeles Capital Management's largest Q1 2023 buy was Bio-Rad Laboratories Class A: 184,796 shares worth $88.5M.
- Los Angeles Capital Management added most to Visa in Q1 2023, an estimated $426M increase.
- Los Angeles Capital Management's biggest Q1 2023 reduction was Pfizer, cutting an estimated $196M.
- Los Angeles Capital Management fully exited Regions Financial in Q1 2023, selling an estimated $50.4M.
- Los Angeles Capital Management's ten largest holdings make up 27% of its $22.5B portfolio in Q1 2023.
- Los Angeles Capital Management opened 164 new positions and closed 194 in Q1 2023.
- Los Angeles Capital Management's portfolio value rose 9.4% quarter-over-quarter to $22.5B.
Based on Los Angeles Capital Management's 13F filing for Q1 2023, filed 4 May 2023.